Home LiteratureArticle Details
PMID: 22189290 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Altered serotonergic function may partially account for behavioral endophenotypes in steroid sulfatase-deficient mice.

Trent S, Cassano T, Bedse G, Ojarikre OA, Humby T, Davies W

Abstract

The X-linked gene STS encodes the steroid hormone-modulating enzyme steroid sulfatase. Loss-of-function of STS, and variation within the gene, have been associated with vulnerability to developing attention deficit hyperactivity disorder (ADHD), a neurodevelopmental condition characterized by inattention, severe impulsivity, hyperactivity, and motivational deficits. ADHD is commonly comorbid with a variety of disorders, including obsessive-compulsive disorder. The neurobiological role of steroid sulfatase, and therefore its potential role in ADHD and associated comorbidities, is currently poorly understood. The 39,X(Y)*O mouse, which lacks the Sts gene, exhibits several behavioral abnormalities relevant to ADHD including inattention and hyperactivity. Here, we show that, unexpectedly, 39,X(Y)*O mice achieve higher ratios than wild-type mice on a progressive ratio (PR) task thought to index motivation, but that there is no difference between the two groups on a behavioral task thought to index compulsivity (marble burying). High performance liquid chromatography analysis of monoamine levels in wild type and 39,X(Y)*O brain tissue regions (the frontal cortex, striatum, thalamus, hippocampus, and cerebellum) revealed significantly higher levels of 5-hydroxytryptamine (5-HT) in the striatum and hippocampus of 39,X(Y)*O mice. Significant correlations between hippocampal 5-HT levels and PR performance, and between striatal 5-HT levels and locomotor activity strongly implicate regionally-specific perturbations of the 5-HT system as a neurobiological candidate for behavioral differences between 40,XY and 39,X(Y)*O mice. These data suggest that inactivating mutations and functional variants within STS might exert their influence on ADHD vulnerability, and disorder endophenotypes through modulation of the serotonergic system.

MeSH Terms
Acoustic Stimulation/methods Age Factors Animals Biogenic Monoamines/metabolism Brain/metabolism Chromatography, High Pressure Liquid Disease Models, Animal Endophenotypes Exploratory Behavior/physiology Ichthyosis, X-Linked/genetics,metabolism,pathology,physiopathology Mice Reinforcement, Psychology Serotonin/metabolism Statistics, Nonparametric Steryl-Sulfatase/genetics
Chemicals
Biogenic Monoamines Serotonin Steryl-Sulfatase
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Trent Simon
Behavioral Genetics Group, Schools of Medicine and Psychology, Cardiff University, Cardiff, UK.
Cassano Tommaso
Bedse Gaurav
Ojarikre Obah A
Humby Trevor
Davies William
References (48)
48 references, click to expand
  1. Effect of methylphenidate on motivation in children with attention-deficit/hyperactivity disorder.
    Exp Clin Psychopharmacol. 2011 Apr;19(2):145-53 PMID: 21463072
  2. Assessing motivation in children using a progressive ratio task.
    Behav Processes. 2011 Jun;87(2):203-9 PMID: 21507343
  3. Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates.
    Neurosci Biobehav Rev. 2012 Jan;36(1):47-63 PMID: 21527287
  4. Identifying molecular substrates in a mouse model of the serotonin transporter x environment risk factor for anxiety and depression.
    Biol Psychiatry. 2008 May 1;63(9):840-6 PMID: 17949690
  5. Effect of paroxetine on marble-burying behavior in mice.
    Methods Find Exp Clin Pharmacol. 2005 Dec;27(10):685-7 PMID: 16395417
  6. Steroid sulfatase-deficient mice exhibit endophenotypes relevant to attention deficit hyperactivity disorder.
    Psychoneuroendocrinology. 2012 Feb;37(2):221-9 PMID: 21723668
  7. Contiguous gene syndrome due to an interstitial deletion in Xp22.3 in a boy with ichthyosis, chondrodysplasia punctata, mental retardation and ADHD.
    Eur J Med Genet. 2007 Jul-Aug;50(4):301-8 PMID: 17591464
  8. Neurosteroids modulate compulsive and persistent behavior in rodents: implications for obsessive-compulsive disorder.
    Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1161-6 PMID: 19549549
  9. Converging methods in studying attention-deficit/hyperactivity disorder: what can we learn from neuroimaging and genetics?
    Dev Psychopathol. 2008 Fall;20(4):1133-43 PMID: 18838034
  10. Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion.
    Neurochem Res. 2009 Aug;34(8):1417-26 PMID: 19229609
  11. Acute dehydroepiandrosterone treatment exerts different effects on dopamine and serotonin turnover ratios in the rat corpus striatum and nucleus accumbens.
    Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1584-9 PMID: 18585426
  12. Forebrain-specific expression of monoamine oxidase A reduces neurotransmitter levels, restores the brain structure, and rescues aggressive behavior in monoamine oxidase A-deficient mice.
    J Biol Chem. 2007 Jan 5;282(1):115-23 PMID: 17090537
  13. Xp deletions associated with autism in three females.
    Hum Genet. 1999 Jan;104(1):43-8 PMID: 10071191
  14. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
    Dev Disabil Res Rev. 2010;16(3):273-82 PMID: 20981766
  15. Obsessive-compulsive and spectrum disorders in children and adolescents.
    Psychiatr Clin North Am. 2006 Jun;29(2):353-70 PMID: 16650713
  16. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry.
    Psychopharmacology (Berl). 2002 Oct;163(3-4):362-80 PMID: 12373437
  17. Understanding attention-deficit/hyperactivity disorder from childhood to adulthood.
    Postgrad Med. 2010 Sep;122(5):97-109 PMID: 20861593
  18. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation.
    Annu Rev Neurosci. 2009;32:267-87 PMID: 19555290
  19. Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype.
    Eur J Neurosci. 1999 Aug;11(8):2813-23 PMID: 10457178
  20. Parent-, teacher-, and self-rated motivational styles in ADHD subtypes.
    J Learn Disabil. 2002 Mar-Apr;35(2):104-13 PMID: 15490739
  21. Is there an inhibitory-response-control system in the rat? Evidence from anatomical and pharmacological studies of behavioral inhibition.
    Neurosci Biobehav Rev. 2010 Jan;34(1):50-72 PMID: 19615404
  22. Genetic and pharmacological evidence that 5-HT2C receptor activation, but not inhibition, affects motivation to feed under a progressive ratio schedule of reinforcement.
    Pharmacol Biochem Behav. 2010 Nov;97(1):170-8 PMID: 20624416
  23. Attention deficit/hyperactivity disorder: a review and update.
    J Pediatr Nurs. 2008 Oct;23(5):345-57 PMID: 18804015
  24. Neural mechanisms of aggression.
    Nat Rev Neurosci. 2007 Jul;8(7):536-46 PMID: 17585306
  25. Chronic blockade or constitutive deletion of the serotonin transporter reduces operant responding for food reward.
    Neuropsychopharmacology. 2007 Nov;32(11):2321-9 PMID: 17356573
  26. Serotonin and brain development.
    Int Rev Neurobiol. 2004;59:111-74 PMID: 15006487
  27. The meiotic checkpoint monitoring synapsis eliminates spermatocytes via p53-independent apoptosis.
    Nat Genet. 1998 Mar;18(3):257-61 PMID: 9500548
  28. X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits.
    J Med Genet. 2008 Aug;45(8):519-24 PMID: 18413370
  29. An Xp; Yq translocation causing a novel contiguous gene syndrome in brothers with generalized epilepsy, ichthyosis, and attention deficits.
    Epilepsia. 2003 Dec;44(12):1529-35 PMID: 14636323
  30. Synchronized activity between the ventral hippocampus and the medial prefrontal cortex during anxiety.
    Neuron. 2010 Jan 28;65(2):257-69 PMID: 20152131
  31. Neurosteroids: endogenous role in the human brain and therapeutic potentials.
    Prog Brain Res. 2010;186:113-37 PMID: 21094889
  32. Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder.
    Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1531-5 PMID: 18937300
  33. Dissociable regulation of instrumental action within mouse prefrontal cortex.
    Eur J Neurosci. 2010 Nov;32(10):1726-34 PMID: 21044173
  34. Role of the serotonin system in ADHD: treatment implications.
    Expert Rev Neurother. 2007 Oct;7(10):1357-74 PMID: 17939772
  35. Converging pharmacological and genetic evidence indicates a role for steroid sulfatase in attention.
    Biol Psychiatry. 2009 Aug 15;66(4):360-7 PMID: 19251250
  36. Polymorphisms of the steroid sulfatase (STS) gene are associated with attention deficit hyperactivity disorder and influence brain tissue mRNA expression.
    Am J Med Genet B Neuropsychiatr Genet. 2010 Dec 5;153B(8):1417-24 PMID: 20862695
  37. Expression of steroid sulfatase during embryogenesis.
    Endocrinology. 1997 Nov;138(11):4768-73 PMID: 9348204
  38. Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition.
    Brain Res. 1997 Oct 31;773(1-2):28-32 PMID: 9409701
  39. From genes to aggressive behavior: the role of serotonergic system.
    Bioessays. 2006 May;28(5):495-503 PMID: 16615082
  40. Steroid sulfatase is a potential modifier of cognition in attention deficit hyperactivity disorder.
    Genes Brain Behav. 2011 Apr;10(3):334-44 PMID: 21255266
  41. Steroid sulfatase: molecular biology, regulation, and inhibition.
    Endocr Rev. 2005 Apr;26(2):171-202 PMID: 15561802
  42. Loss of the imprinted snoRNA mbii-52 leads to increased 5htr2c pre-RNA editing and altered 5HT2CR-mediated behaviour.
    Hum Mol Genet. 2009 Jun 15;18(12):2140-8 PMID: 19304781
  43. On the applied use of progressive-ratio schedules of reinforcement.
    J Appl Behav Anal. 2008 Summer;41(2):155-61 PMID: 18595280
  44. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.
    J Neurosci Res. 2004 Oct 15;78(2):289-96 PMID: 15378510
  45. Intracranial dehydroepiandrosterone blocks the activation of tryptophan hydroxylase in response to acute sound stress.
    Mol Cell Neurosci. 1994 Apr;5(2):176-81 PMID: 8032685
  46. Doubly dissociable effects of median- and dorsal-raphé lesions on the performance of the five-choice serial reaction time test of attention in rats.
    Behav Brain Res. 1997 Dec;89(1-2):135-49 PMID: 9475622
  47. Absence of learning difficulties in a hyperactive boy with a terminal Xp deletion encompassing the MRX49 locus.
    J Med Genet. 2001 Jul;38(7):466-70 PMID: 11474655
  48. Schizophrenia susceptibility gene locus at Xp22.3.
    Clin Genet. 1999 Jun;55(6):455-60 PMID: 10450863
Article Info
Journal
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Abbr.
Neuropsychopharmacology
ISSN
1740-634X
Published
2012-04-00
Epub
2011-00-21
Pages
1267-74
Language
English
Region
England
NLM ID
8904907
PMCID
PMC3306888
Subset
IM
Grants
Medical Research Council · G0900636 · United Kingdom
Medical Research Council · G0900636(91052) · United Kingdom
Medical Research Council · 91052 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com